PL3532028T3 - Kompozycje farmaceutyczne zawierające ester kwasu fumarowego i sposób ich przygotowania - Google Patents
Kompozycje farmaceutyczne zawierające ester kwasu fumarowego i sposób ich przygotowaniaInfo
- Publication number
- PL3532028T3 PL3532028T3 PL17794229.9T PL17794229T PL3532028T3 PL 3532028 T3 PL3532028 T3 PL 3532028T3 PL 17794229 T PL17794229 T PL 17794229T PL 3532028 T3 PL3532028 T3 PL 3532028T3
- Authority
- PL
- Poland
- Prior art keywords
- preparing
- acid ester
- pharmaceutical compositions
- fumaric acid
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20160100551A GR1009149B (el) | 2016-10-25 | 2016-10-25 | Φαρμακευτικα σκευασματα που περιλαμβανουν εναν εστερα φουμαρικου οξεως και μεθοδος παραγωγης αυτων |
| PCT/EP2017/025317 WO2018077479A1 (en) | 2016-10-25 | 2017-10-25 | Pharmaceutical compositions comprising a fumaric acid ester and method for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3532028T3 true PL3532028T3 (pl) | 2026-01-26 |
Family
ID=60262884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17794229.9T PL3532028T3 (pl) | 2016-10-25 | 2017-10-25 | Kompozycje farmaceutyczne zawierające ester kwasu fumarowego i sposób ich przygotowania |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10894026B2 (pl) |
| EP (1) | EP3532028B1 (pl) |
| AU (1) | AU2017348941B2 (pl) |
| BR (1) | BR112019007861A2 (pl) |
| CA (1) | CA3039820C (pl) |
| ES (1) | ES3053341T3 (pl) |
| GR (1) | GR1009149B (pl) |
| PL (1) | PL3532028T3 (pl) |
| WO (1) | WO2018077479A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201818293A2 (tr) * | 2018-11-30 | 2020-06-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Di̇meti̇l fumarat i̇çeren geci̇kmeli̇ salim sağlayan kapsül |
| CA3135946C (en) * | 2019-05-31 | 2022-08-09 | Myung-Hwa Kim | Enteric tablet containing dimethyl fumarate |
| WO2022254356A1 (en) * | 2021-06-04 | 2022-12-08 | Zim Laboratories Limited | Delayed release compositions of dimethyl fumarate |
| CN116251074B (zh) * | 2023-04-19 | 2025-02-11 | 四川宏明博思药业有限公司 | 一种富马酸二甲酯肠溶片以及肠溶胶囊 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5891474A (en) | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
| DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| ES2411972T5 (es) | 2009-01-09 | 2021-10-27 | Fwp Ip Aps | Formulación farmacéutica que comprende uno o más ésteres de ácido fumárico en una matriz de erosión |
| JP2012525385A (ja) * | 2009-04-29 | 2012-10-22 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 神経変性および神経炎症の治療 |
| US20160206586A1 (en) | 2013-08-26 | 2016-07-21 | Forward Pharma A/S | Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose |
| US20150079180A1 (en) | 2013-09-18 | 2015-03-19 | Xenoport, Inc. | Nanoparticle compositions of dimethyl fumarate |
| CN104027311A (zh) * | 2014-05-09 | 2014-09-10 | 万特制药(海南)有限公司 | 一种含有富马酸二甲酯的肠溶缓释微丸 |
| CN104352441B (zh) * | 2014-10-16 | 2017-06-09 | 山东百诺医药股份有限公司 | 一种富马酸二甲酯肠溶微丸及其制备方法 |
| US20180064653A1 (en) * | 2015-03-17 | 2018-03-08 | Hetero Labs Limited | Pharmaceutical compositions of dimethyl fumarate |
| CN104971048B (zh) | 2015-07-01 | 2019-01-18 | 上海汇伦医药科技有限公司 | 富马酸二甲酯肠溶微丸及其制备方法 |
| WO2017114594A1 (en) * | 2015-12-31 | 2017-07-06 | Zaklady Farmaceutyczne Polpharma S.A. | Enteric coated oral pharmaceutical preparation comprising dimethyl fumarate |
-
2016
- 2016-10-25 GR GR20160100551A patent/GR1009149B/el active IP Right Grant
-
2017
- 2017-10-25 EP EP17794229.9A patent/EP3532028B1/en active Active
- 2017-10-25 US US16/339,281 patent/US10894026B2/en active Active
- 2017-10-25 BR BR112019007861A patent/BR112019007861A2/pt not_active Application Discontinuation
- 2017-10-25 AU AU2017348941A patent/AU2017348941B2/en active Active
- 2017-10-25 PL PL17794229.9T patent/PL3532028T3/pl unknown
- 2017-10-25 CA CA3039820A patent/CA3039820C/en active Active
- 2017-10-25 ES ES17794229T patent/ES3053341T3/es active Active
- 2017-10-25 WO PCT/EP2017/025317 patent/WO2018077479A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017348941B2 (en) | 2023-11-09 |
| AU2017348941A1 (en) | 2019-06-13 |
| EP3532028B1 (en) | 2025-08-20 |
| EP3532028A1 (en) | 2019-09-04 |
| US20200046670A1 (en) | 2020-02-13 |
| WO2018077479A1 (en) | 2018-05-03 |
| BR112019007861A2 (pt) | 2019-07-02 |
| CA3039820C (en) | 2022-08-30 |
| GR1009149B (el) | 2017-10-31 |
| US10894026B2 (en) | 2021-01-19 |
| CA3039820A1 (en) | 2018-05-03 |
| ES3053341T3 (en) | 2026-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201707981B (en) | Compositions of obeticholic acid and methods of use | |
| DK3386484T3 (da) | Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler | |
| LT3362049T (lt) | Kamptotecino farmacinių kompozicijų stabilizavimas | |
| EP3563853C0 (en) | COMPOSITION OF MANNURONIC DIACID | |
| PL3710036T3 (pl) | Stabilne kompozycje kwasu askorbinowego i sposoby ich zastosowania | |
| LT3116491T (lt) | Terapiškai aktyvių junginių farmacinės kompozicijos | |
| IL256322B (en) | Improved formulations of deferasirox and methods of making the same | |
| PL3359632T3 (pl) | Kompozycje zawierające aminę cukrową i kwas tłuszczowy | |
| IL247529B (en) | Preparations of choline ester lipoic acid and methods of use | |
| PL3606929T3 (pl) | Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania | |
| EP3501517C0 (en) | ALL-TRANS RETINOIC ACID INJECTABLE FORMULATION | |
| IL262233B (en) | Prodrug of amino acid derivative | |
| IL249348A0 (en) | A new preparation and method for synthesis | |
| DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
| PL3532028T3 (pl) | Kompozycje farmaceutyczne zawierające ester kwasu fumarowego i sposób ich przygotowania | |
| PL3164116T3 (pl) | Kompozycje musujące zawierające kokryształy części kwasowej | |
| SG10202008700VA (en) | α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| ITUB20153460A1 (it) | Composizioni cosmetiche acquose contenenti esteri dell?acido pelargonico | |
| ITUB20153461A1 (it) | Composizioni cosmetiche lipofile contenenti esteri dell?acido pelargonico | |
| EP3367998A4 (en) | NOVEL METHOD OF USE AND COMPOSITIONS | |
| EP3379936A4 (en) | TRICHOM AND PISTILLIFICATION FORMULATION | |
| ITUB20153490A1 (it) | Miscele di esteri dell?acido pelargonico | |
| DK3349748T3 (da) | Sammensætninger omfattende feenugreek-ekstrakter og fremgangsmåder til fremstilling deraf | |
| IL253824A0 (en) | Pharmaceutical formulations of c1 esterase inhibitor | |
| ITUB20153463A1 (it) | Composizioni cosmetiche a base di polveri contenenti esteri dell?acido pelargonico |